Haemonetics (HAE) Competitors

Merit Medical Systems (NASDAQ:MMSI) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability, earnings and community ranking.

Do insiders & institutionals believe in MMSI or HAE?

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 1.8% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more risk & volatility, MMSI or HAE?

Merit Medical Systems has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.

Does the media prefer MMSI or HAE?

In the previous week, Merit Medical Systems had 18 more articles in the media than Haemonetics. MarketBeat recorded 33 mentions for Merit Medical Systems and 15 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.32 beat Merit Medical Systems' score of 0.71 indicating that Haemonetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	15 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	12 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate MMSI or HAE?

Merit Medical Systems presently has a consensus target price of $107.78, indicating a potential upside of 15.64%. Haemonetics has a consensus target price of $101.22, indicating a potential upside of 60.46%. Given Haemonetics' higher probable upside, analysts plainly believe Haemonetics is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	3.00
Haemonetics	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.78

Which has stronger valuation and earnings, MMSI or HAE?

Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.36B	4.06	$94.41M	$2.04	45.69
Haemonetics	$1.37B	2.31	$117.56M	$2.54	24.84

Is MMSI or HAE more profitable?

Haemonetics has a net margin of 9.47% compared to Merit Medical Systems' net margin of 9.05%. Haemonetics' return on equity of 23.66% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.05%	15.61%	8.38%
Haemonetics	9.47%	23.66%	8.82%

Does the MarketBeat Community prefer MMSI or HAE?

Merit Medical Systems received 54 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 70.22% of users gave Merit Medical Systems an outperform vote while only 61.60% of users gave Haemonetics an outperform vote.

Company	Underperform	Outperform
Merit Medical Systems	Outperform Votes 455 70.22%	Underperform Votes 193 29.78%
Haemonetics	Outperform Votes 401 61.60%	Underperform Votes 250 38.40%

Summary

Merit Medical Systems and Haemonetics tied by winning 9 of the 18 factors compared between the two stocks.